Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Long-Term Investments (2016 - 2025)

Fresenius Medical Care AG has reported Long-Term Investments over the past 17 years, most recently at $772.5 million for Q4 2025.

  • Quarterly results put Long-Term Investments at $772.5 million for Q4 2025, up 16.45% from a year ago — trailing twelve months through Dec 2025 was $772.5 million (up 16.45% YoY), and the annual figure for FY2025 was $772.5 million, up 16.45%.
  • Long-Term Investments for Q4 2025 was $772.5 million at Fresenius Medical Care AG, up from $663.4 million in the prior quarter.
  • Over the last five years, Long-Term Investments for FMCQF hit a ceiling of $900.2 million in Q4 2021 and a floor of $663.4 million in Q4 2024.
  • Median Long-Term Investments over the past 5 years was $772.5 million (2025), compared with a mean of $763.5 million.
  • Biggest five-year swings in Long-Term Investments: fell 12.37% in 2023 and later increased 16.45% in 2025.
  • Fresenius Medical Care AG's Long-Term Investments stood at $900.2 million in 2021, then decreased by 12.31% to $789.4 million in 2022, then decreased by 12.37% to $691.8 million in 2023, then dropped by 4.1% to $663.4 million in 2024, then increased by 16.45% to $772.5 million in 2025.
  • The last three reported values for Long-Term Investments were $772.5 million (Q4 2025), $663.4 million (Q4 2024), and $691.8 million (Q4 2023) per Business Quant data.